Evotec SE (EVO) Tax Provisions (2009 - 2025)
Evotec SE (EVO) posted Tax Provisions of $19.5 million for Q4 2025, up 13134819.37% sequentially from -$148.47 in Q3 2025, and up 777.74% YoY from $2.2 million in Q4 2024.
Evotec SE (EVO) Tax Provisions (2009 - 2025) Analysis & Trends
Evotec SE has reported Tax Provisions for 9 years, with the latest figure at $19.5 million in Q4 2025.
- Quarterly Tax Provisions rose 777.74% year-over-year to $19.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.7 million (up 273.14% YoY) and the FY2025 annual result came in at $19.5 million, up 768.09% from the prior year.
- Tax Provisions rose to $19.5 million in Q4 2025 per EVO's latest filing, from -$148.47 in the prior quarter.
- Over five years, Tax Provisions peaked at $24.6 million in Q4 2021 and troughed at -$8366.2 in Q2 2023.
- A 5-year average of $4.8 million and a median of $5458.9 in 2021 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions plunged 207.09% in 2022, then soared 777.74% in 2025.
- Over 5 years, Tax Provisions stood at $24.6 million in 2021, then dropped by 9.88% to $22.1 million in 2022, then sank by 83.8% to $3.6 million in 2023, then plunged by 38.01% to $2.2 million in 2024, then surged by 777.74% to $19.5 million in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered $19.5 million, -$148.47, and $2.2 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evotec SE | 681.90 Mn | 681.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.50 Mn |
| Sep 30, 2025 | -148.47 |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 7,952.21 |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 9,839.77 |
| Jun 30, 2023 | -8,366.21 |
| Dec 31, 2022 | 22.13 Mn |
| Sep 30, 2022 | 3,943.36 |
| Jun 30, 2022 | -3,842.47 |
| Mar 31, 2022 | -4,272.74 |
| Dec 31, 2021 | 24.55 Mn |
| Sep 30, 2021 | 5,458.92 |
| Jun 30, 2021 | -1,251.24 |
| Mar 31, 2021 | -2,886.52 |
| Dec 31, 2020 | 23.31 Mn |
| Sep 30, 2020 | 6,981.60 |
| Dec 31, 2019 | 21.43 Mn |
| Sep 30, 2010 | -171.74 |
| Jun 30, 2010 | 12.75 |